Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngioma by Couldwell, William T. & Chakabarti, Indro
J Neurosurg 102:650-657, 2005
Long-term neurological, visual, and endocrine outcomes 
following transnasal resection of craniopharyngioma
Indro Chakrabarti, M.D., M.P.H., A run P. A mar, M.D.,
W illiam Couldwell, M.D., Ph.D., and M artin H. W eiss, M.D.
Department o f  Neurological Surgery, University o f  Southern California, Los Angeles, California; 
Department o f  Neurosurgery, Yale University, New Haven, Connecticut; and Department o f  
Neurosurgery, University o f  Utah, Salt Lake City, Utah
Object. The authors report on a cohort of patients with craniopharyngioma treated principally through transnasal (TN) 
resection and followed up for a minimum of 5 years. More specifically, they evaluate the role of the TN approach in the 
management of craniopharyngioma.
Methods. Between 1984 and 1994, 68 patients underwent TN resection of craniopharyngiomas at the University of 
Southern California. The tumor was at least partially cystic in 88% of cases. Four tumors were purely intrasellar, 53 had 
intra- and suprasellar components, and 11 were exclusively suprasellar. During the same period, 18 patients underwent 
transcranial (TC) resection of purely suprasellar craniopharyngiomas. Long-term neurological, visual, and endocrine out­
comes were reviewed for all patients.
In 61 (90%) of 68 patients in the TN group, total resection was achieved, according to 3-month postoperative magnet­
ic resonance images, although four patients suffered a recurrence. Three (43%) of the seven tumors that had been partial­
ly resected were enlarged on serial imaging. Fifty-four (87%) of 62 patients with preoperative visual loss experienced im­
provement in one or both eyes, but two patients (3%) with exclusively suprasellar tumors experienced postoperative visual 
worsening in one or both eyes. New instances of postoperative endocrinopathy (that is, not present preoperatively) oc­
curred as follows: hypogonadism (eight of 22 cases), growth hormone (GH) deficiency (four of 18 cases), hypothyroidism 
(11 of 49 cases), hypocortisolemia (nine of 52 cases), and diabetes insipidus (DI; four of 61 cases). One case each of hy- 
pocortisolemia and hypothyroidism resolved after surgery. Hypeiphagia occurred in 27 (40%) of 68 patients. One patient 
had short-term memory loss. Postoperative complications included one case of cerebrospinal fluid leak.
Among the 18 patients in the TC group, 11 had complete resections. In one case (9%) the tumors recurred. Three (43%) 
of the seven subtotally resected tumors grew during the follow-up interval. Vision improved in 11 (61%) of 18 cases and 
worsened in three (17%) as a result of surgery. New instances of postoperative endocrinopathy occurred as follows: hypo­
gonadism (one of six cases), GH deficiency (four of seven cases), hypothyroidism (11 of 14 cases), hypocortisolemia (eight 
of 15 cases), and DI (nine of 16 cases). No instance of preoperative endocrinopathy was corrected through TC surgery. 
Four patients (22%) exhibited short-term memory loss and 11 (61%) had hypeiphagia after surgery. When compared with 
those in the TC group, patients in the TN group had shorter hospital stays.
Conclusions. Use of the TN approach can render good outcomes in properly selected patients with craniopharyngioma, 
particularly when the tumor is cystic. Even in mostly suprasellar cases, an extended TN approach can afford complete 
resection. Note that endocrine function often worsens after surgery and that postoperative obesity can be a significant 
problem.
K ey W ords • craniopharyngioma • long-term outcome • endocrine outcome • 
extended transsphenoidal approach
RANtoPHARYNGtOMA is a rare tumor having a cal­
I  culated incidence of 338 cases per year in the US, 
V _ ^  with one third occurring in children younger than 14 
years of age.3 Although histologically benign, the lesion’s 
potential for adhesion to vital brain structures makes total 
resection, and thus cure, difficult. The challenges presented 
by this tumor have been well documented.2-4-6-11-16-24-25-34-37-39- 
4245 Removal of the tumor at the expense of pituitary func­
tion has become clinically tolerable with the development 
of hormonal replacement therapy.17 Nonetheless, surgical 
cure that results in hypothalamic or optic injury can be un­
acceptable.
Abbreviations used in this paper: (3HCG = beta human chorionic 
gonadotropin; CSF = cerebrospinal fluid; DI = diabetes insipidus; 
GH = growth hormone; MR = magnetic resonance; TC = transcrani­
al; TN = transnasal.
Neurosurgeons currently disagree on the optimal man­
agement of craniopharyngiomas. Although some advocate 
complete tumor removal,12-41'-45 others favor limited resection 
followed by radiotherapy.2-11-25 Surgical removal of the tu­
mor can be accomplished through a variety of corridors 
including TC (pterional, subfrontal, subtemporal, and bi- 
frontal-interhemispheric) or TN routes.16-27-32-45 In this study, 
we aimed to elucidate the current role of TN surgery for cra­
niopharyngioma in an era of sophisticated microsurgery and 
advancing radiosurgery.
Although there is consensus that purely intrasellar' cranio­
pharyngiomas should be removed via the TN approach, 
these tumors are rare. No such consensus exists for cra­
niopharyngiomas that are suprasellar' or have significant 
suprasellar extension. The TN approach has advantages 
over other routes, including a reduced postoperative hospi­
tal stay.12-21-24-27 The possibility of incomplete resection, how-
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ever, as well as the risk of CSF leaks has generated concerns 
about the TN approach. We report on a series of 86 patients 
with craniopharyngiomas; a TN approach was used in 68 
patients and a TC route was followed in 18. Although some 
investigators have examined the TN approach for cranio­
pharyngioma,’6 rigorous pre- and postoperative endocrine 
data have not been previously reported in the neurosurgical 
literature. The use of the extended TN approach for supra­
sellar tumors is also discussed.
Clinical Material and Methods
Patient Population
Between 1984 and 1994, 86 patients underwent surgi­
cal treatment for craniopharyngioma (M.H.W.). These dates 
were selected to limit the study to patients with at least 5 
years of follow up and those who had undergone MR im­
aging. In each case, the operation was the exclusive proce­
dure performed in the patient; that is, none of the patients 
had prior or repeated surgery. All tumors were histological­
ly confirmed through permanent staining of intraoperatively 
obtained tissue sections. Cases with questionable or mixed 
pathology were not included in this series.
We retrospectively reviewed the hospital charts and im­
aging studies for each of the patients. All research was con­
ducted in accordance with local institutional review board 
policies. The patients were grouped according to surgical 
approach (TN compared with TC) and analyzed for surgical 
data, endocrine and visual outcomes, long-term morbidity 
and mortality rates, and recurrence rates.
The TN group comprised 68 patients (35 female and 33 
male) ranging in age from 30 months to 73 years. The 18 
patients (10 men and eight women) included in the TC 
group had ages rangning from 22 to 76 years. The TN route 
was selected in all cases in which the tumor was purely in­
trasellar (four cases), intrasellar with suprasellar extension 
and predominantly cystic (53 cases), or purely suprasellar 
and cystic (11 cases; Table 1). Altogether 60 (88%) of 68 
patients in the TN group harbored at least partially cystic le­
sions. The eight solid lesions were intrasellar tumors, four 
having a small suprasellar extension. The TC method was 
chosen when the lesion’s suprasellar component was pre­
ponderant and solid or lateral to the midline.
Outcome Assessment
Patients were examined (M.H.W.) preoperatively, at 3 
months, and at regular intervals thereafter. Additionally, an 
ophthalmologist evaluated the patients at these times. The 
duration of follow up ranged from 5 to 10 years.
Patients were also treated by endocrinologists. Complete 
serum endocrine panels were obtained preoperatively and 
at 3 months postoperatively. Provocative endocrine testing 
was not performed. Gonadotropin (follicle-stimulating hor­
mone and luteinizing hormone), fasting GH, insulin-like 
growth factor, thyroid-stimulating hormone (T3 and T4), 
fasting morning and 4:00 p.m. cortisol, and prolactin levels 
were tested in all patients except 10 from the TN group and 
four from the TC group who lacked preoperative GH test­
ing. Diabetes insipidus was diagnosed clinically by using 
urine specific gravity and serum sodium levels. Cerebrospi­
nal fluid was withdrawn from five patients with suprasellar
TABLE 1
Tumor characteristics in 86 patients
Tumor Component TN Group (%) TC Group (%)
total no. of tumors 68 18
intrasellar 4(6) 0 (0)
intra- & suprasellar 53 (78) 0 (0)
suprasellar 11 (16) 18 (100)
cvstic & solid 60 (88) 8 (44)
solid 8(12) 10 (56)
solid lesions supposed to be germ cell tumors to look for 
pHCG. All five of these cases were in the TC cohort.
Surgical reports, anesthesia records, and nursing notes 
were analyzed for intra- and perioperative data. Informa­
tion regarding surgical time, blood loss, duration of hospital 
stay, use of transfusion products, and use of graft for closure 
of CSF leaks was also cataloged. Follow up of global out­
comes were recorded in categorical terms. A patient was 
classified as having a “good outcome” if he or she was able 
to return to baseline levels of professional and social func­
tion and did not have neurological deficits, as assessed by 
the patient, physician, and family. Many of these patients re­
quired pituitary replacement therapy, which did not inter­
fere with participation in activities of daily living. Patients 
with some neurological debility and only mildly impaired 
activities of daily living were categorized as having “fair 
outcomes.” All other outcomes were classified as “poor.”
Radiographic Assessment
Radiographic evaluation was performed using preopera­
tive MR imaging in all cases. In addition, most patients also 
had computerized tomography scans and plain skull x-ray 
films available for preoperative planning, especially in the 
TN cases. Postoperatively, we used only MR imaging with 
high-resolution, thin-sectioned enhanced views of the sellar 
and parasellar areas. We did not use computerized tomogra­
phy postoperatively because neuroradiologists at our facil­
ity believe the MR imaging studies are sensitive and suffi­
cient. All images were reviewed by staff neuroradiologists 
and the senior author (M.H.W.). Tumors were evaluated for 
size, diameter, and sprawl above and below the diaphrag- 
ma sellae. All patients underwent MR imaging at 3 months 
postoperatively. Furthermore, MR imaging was repeated 
whenever signs or symptoms indicated recurrence or tumor 
growth.
Of the tumors accessed transnasally, 60 (88%) had mixed 
solid and cystic components; the remaining eight (12%) 
were solid (Table 1). The transcranially approached tumors 
were mixed solid and cystic in eight cases (44%), and the 
remaining 10 cases (56%) were solid.
Although no sign of increased intracranial pressure was 
seen on presentation, two (3%) of the 68 patients in the TN 
and four (22%) of the 18 patients in the TC group demon­
strated hydrocephalus radiographically.
Surgical Approaches
Details of the TN approach have been published previ­
ously.41 In cases in which the tumor was purely intrasellar, 
the standard route was used and only the floor of the sella 
turcica was removed. For tumors with suprasellar exten­
sion, however, the extended TN approach was undertaken.
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Preoperative findings in 86 patients 
harboring craniopharyngioma
TABLE 2
Variable TN Group (%) TC Group (%)
total no. of patients 68 18
visual loss 62/68 (91) 18/18 (100)
endocrinopathy
GH deficiency 40/58 (69) 7/14 (50)
hypogonadism 30/52 (58) 12/18 (67)
hypothyroidism 19/68 (28) 4/18 (22)
hypoadrenalism 16/68 (24) 3/18 (17)
DI7/68 (10) 2/18 (11)
In this extended procedure, bone removal continued across 
the tuberculum toward the planum sphenoidale, thus afford­
ing access to the suprasellar cistern. In cases in which the 
arachnoid had been violated, an abdominal fat graft or ten­
sor fascia lata graft was applied to seal the opening in the 
sellar floor and the sphenoid sinus was packed with fat.
During all TC operations, a standard pterional cranioto­
my was performed followed by subfrontal or transsylvian 
dissection as required. No case was treated using combined 
approaches.
Radiotherapeutic Treatment
All patients who had undergone subtotal resections— as 
demonstrated during surgery or on follow-up imaging— 
were referred for external-beam radiotherapy. Patients re­




Eighty (93%) of the 86 patients in this series had pre­
sented with visual compromise that was confirmed on for­
mal evaluation of visual fields (Table 2). This group con­
sisted of 62 (91%) of 68 patients who had undergone the TN 
procedure and all 18 patients in the TC group. The other six 
patients (7%) had presented with symptoms attributable to 
hypopituitarism and included the four patients with purely 
intrasellar tumors and two of the patients with combined 
intra- and suprasellar tumors. Of the 80 patients who had 
presented with visual loss, 63 (79%) demonstrated some 
form of asymptomatic hypopituitarism on formal testing.
Growth hormone levels were measured in 72 patients, 
and GH deficiency was demonstrated in 40 (69%) of 58 and 
seven (50%) of 14 patients in the TN and TC groups, re­
spectively (Table 2). Gonadotrope function could not be 
measured in 16 patients in the TN group because they were 
too young; of the remaining 52 patients, however, 30 (58%) 
were hypogonadal. Twelve patients (67%) in the TC group 
were hypogonadal. Hypothyroidism was noted in 19 (30%) 
of 68 and four (22%) of 18 patients in the TN and TC 
groups, respectively. Hypocortisolemia was demonstrated 
in 16 patients (24%) in the TN group and three (17%) in the 
TC group. Diabetes insipidus was noted in seven patients 
(10%) from the TN group and two (11%) in the TC group.
Endocrine Outcome
Postoperative endocrine data were tabulated and com-
TABLE 3
Endocrinological function in 86 patients 
following resection o f craniopharyngioma
Variable TN Group (%) TC Group (%)
hypogonadism 38/52 (73) 13/18 (72)
improved cases 0/30 (0) 0/12 (0)
new cases 8/22(36) 1/6(17)
hypothyroidism 30/68 (44) 15/18 (83)
resolved cases 1/19(5) 0/4 (0)
new cases 11/49(22) 11/14 (79)
hypocortisolemia 25/68(37) 11/18 (61)
resolved cases 1/16(6) 0/3 (0)
new cases 9/52(17) 8/15 (53)
DI 48/68 (71) 11/18 (61)
resolved cases 0/7 (0) 0/2 (0)
new cases 41/61 (67) 9/16 (56)
GH deficiency 44/68(65) 11/18 (61)
resolved cases 0/40 (0) 0/7 (0)
new cases 4/18(22) 4/7 (57)
pared (Table 3). Four new cases of GH deficiency occurred 
in both groups of patients; therefore, the postoperative rate 
of GH deficiency was 65 and 61% in the TN and TC co­
horts, respectively. None of the preoperative cases of defi­
ciency resolved after surgery.
Among patients in the TN group who had demonstrated 
no preoperative hypogonadism, eight (36%) of 22 had hy­
pogonadism postoperatively. Inadequate gonadal function 
also occurred in one (17%) of six of the patients in the TC 
group who had revealed no preoperative evidence of the 
disease. Thus, the postoperative incidences of hypogonad­
ism were 73 and 72% in the TN and TC cohorts, respective­
ly. Hypogonadism did not improve in the patients who had 
presented with the disease preoperatively.
New cases of hypothyroidism were discovered in 11 of 
the 49 patients (22%) in the TN group who had not demon­
strated the disease preoperatively, resulting in a postoper­
ative incidence of 44%. In this cohort, only one (5%) of 19 
patients with preoperative hypothyroidism experienced res­
olution of this problem. Eleven (79%) of 14 patients in the 
TC group suffered new cases of hypothyroidism, and none 
of the four with preoperative hypothyroidism improved. 
Thus, 83% of the TC cohort displayed hypothyroidism 
postoperatively.
In the TN group, one (6%) of 16 cases of hypocortisole­
mia resolved. Unfortunately, nine (17%) of 52 patients ac­
quired this insufficiency after surgery. The TC cohort had 
eight (53%) of 15 new cases, with no evidence of any im­
provement among the three who had been hypocortisolemic 
prior to surgery. The postoperative rate of hypocortisolemia 
was 37 and 61% in the TN and TC groups, respectively.
Diabetes insipidus was the most common iatrogenic en­
docrinopathy in both cohorts. It postoperatively occurred in 
41 (67%) of 61 patients in the TN group and nine (56%) of 
16 in the TC cohort. Preoperative cases of DI did not im­
prove with surgery in either group. Thus, the postopera­
tive incidences of DI were 71 and 61% in the TN and TC 
groups, respectively.
In the five cases of suspected germ cell tumors in the 
TC cohort, preoperative (3HCG levels ranged from 8 to 26
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TABLE 4
Visual outcome in 86 patients following 
resection o f craniopharyngioma
Vision Status TN Group (%) TC Group (%)
improved 54/62 (87) 11/18(61)
unchanged 12/68 (18) 4/18 (22)
worsened 2/68 (3) 3/18 (17)
Functional Outcome
Common experiences in both groups of patients were 
hyperphagia and weight gain. In particular, they occurred in 
27 (40%) of 68 patients in the TN group. Hyperphagia was 
also seen in 11 (61 %) of 18 cases in the TC group. Postop­
erative obesity remained a significant problem in these pa­
tients.
Short-term memory loss occurred in one (1.5%) of 68 in 
the TN group and four (22%) of 18 in the TC group. This 
deficit remained stable on long-term follow up.
No patient died during the follow-up period, and no alter­
ation of consciousness occurred in either cohort. Ninety- 
four percent of the patients in this series had good out­
comes, including 67 (99%) of 68 in the TN group and 14 
(78%) of 18 in the TC group. All of these patients resumed 
preoperative levels of social and professional activity. The 
five patients with memory loss were unable to resume their 
preoperative professional status and were thus assessed as 
having a fair outcome. No patient was assessed as having a 
poor outcome.
H ydrocephalus Outcome
Neither of the two patients with ventriculomegaly in the 
TN group had signs of hindered CSF circulation postopera­
tively. Follow-up MR images demonstrated resolution, and 
the patients did not require placement of a shunt. Two of the 
four patients with ventriculomegaly in the TC group had 
clinically and radiographically apparent hydrocephalus fol­
lowing surgery and required a second procedure for shunt 
placement.
Visual Outcome
On postoperative evaluation, two (3%) of 68 patients 
who had undergone TN procedures experienced worsening 
of their preoperative visual loss, including one patient with 
binocular deterioration (Table 4). Both of these patients had 
exclusively suprasellar tumors. Visual symptoms were ame­
liorated in 54 (87%) of 62 patients with preoperative visu­
al impairment. The other 12 patients in the TN group had 
no change in vision, including all six patients who had 
presented with hypopituitarism. Among the patients in the 
TC group, three (17%) of 18 suffered worsening of vision, 
including two with binocular deterioration. Eleven (61 %) of 
18 didhave some improvement of vision following removal 
of the tumor via the TC approach. No person was rendered 
blind in any eye.
Perioperative Data
The surgical time ranged from 53 to 105 minutes in the 
TN group and from 222 to 308 minutes in the TC group. 
Blood loss in the TN cohort was 30 to 180 mJ, whereas it 
was 160 to 350 mJ in the TC group. No patient in either
Complications following resection o f 
craniopharyngioma in 86 patients
TABLE 5
Variable TN Group (%) TC Group (%)
total no. of patients 68 18
CSF leak K D 0 (0)
meningitis 0 (0) 1(5)
short-term memory loss K D 4(22)
hyperphagia 27 (40) 11 (61)
group required a blood transfusion. The mean duration of 
the hospital stay was 4.2 and 7.8 days in the TN and TC 
groups, respectively. Intraoperative repair of CSF leaks 
(graft for closure) in the TN group was required in 58 (85%) 
of 68 cases.
Perioperative Complications
In the TN group, only one case of CSF leak occurred 
postoperatively (Table 5). This leak was successfully treat­
ed during a second procedure, that is, endoscopically guid­
ed sinus packing with autologous fat. No case of meningitis 
occurred. No CSF leak was noted in the TC group, but there 
was one case of meningitis (one [6%] of 18). This disease 
was treated using antibiotic agents alone without further se­
quelae.
Recurrence Rates
Total resection was confirmed on 3-month postoperative 
MR imaging in the TN group in 61 cases (90%). Of the 
seven patients (10%) in the TN group who had undergone 
subtotal resections, five subsequently received convention­
al fractionated radiotherapy. Among the 61 patients in the 
TN group who had demonstrated total resection on 3-month 
postoperative imaging studies, we counted four recurrences 
(7%) based on MR images obtained during the 5 - to 10-year 
follow ups. Three (43%) of seven subtotally resected cas­
es in the TN group had progressive tumor enlargement on 
serial imaging, including two patients who had not received 
radiotherapy. These numbers yield a total recurrence rate of 
10% (seven of 68 cases).
Among the cohort who underwent the TC approach, total 
resection was confirmed on 3-month postoperative MR im­
aging in 11 cases (61 %). Six of the seven subtotally resected 
tumors were treated with adjuvant conventional radiother­
apy, as mentioned earlier. On the 5- to 10-year follow-up 
imaging studies, recurrence was noted in one (9%) of 11 to­
tally resected lesions and progressive enlargement in three 
(43%) of seven subtotally removed tumors including two 
not previously radiated. Therefore, four (22%) of 18 pa­
tients treated via the TC approach experienced recurrences.
Discussion
M anagem ent Philosophy
As stated by Van Effenterre and Boch,4U the goal of crani­
opharyngioma surgery should be “complete removal with 
improved visual function, minimal deterioration of endo­
crine function, and no neuropsychological impairment.” 
Clearly, radical resection that results in impaired memory 
or level of consciousness cannot be considered acceptable.
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F ig. 1. Coronal (left) and axial (center} Tr weighted postcontrast MR images obtained preoperatively, demonstrating 
a suprasellar craniopharyngioma with nodular and cystic portions. The tumor was approached via an extended transsphe­
noidal route. A coronal MR image (right) obtained 4 years after surgery, revealing complete resection.
Note, however, that endocrine loss can be overcome by us­
ing hormonal replacement therapy, thus allowing the sur­
geon to be more aggressive. Much less forgiving is injury to 
the hypothalamus, vasculature, or optic apparatus. A sub­
total resection, especially in young patients, almost always 
requires further surgery or radiotherapy with a decreased 
chance of complete tumor removal compared with that on 
the initial encounter. The goal for the surgeon, in our opin­
ion, is the removal of as much tumor as possible during the 
initial operation while leaving the rest for control with ra­
diosurgery. Maintaining a good quality of life is the precept. 
It is easier to accept a subtotal resection than a serious com­
plication.
Attempts to radically excise have rendered significant 
morbidity, although the procedure has its proponents.4-1634- 
-<7.w.45 in a review of 144 cases treated through surgery in 
which the goal was total removal in every case, 90% had 
complete resections.45 Of these totally resected cases, 67.4% 
had good clinical outcomes, whereas there was a 16.7% 
mortality rate and a 16% morbidity rate. Authors of anoth­
er large surgical series with a more conservative surgical 
outlook reported 59% total and 29% subtotal resections.41' 
Note, however, that 13 and 33%, respectively, of the cas­
es in these two groups recurred and most were treated with 
repeated surgery. No patient was referred for radiotherapy. 
On long-term neuropsychological testing, 91% had nor­
mal social integration. An even more conservative approach 
was taken in another surgical series in which the authors 
achieved complete resection in only seven (9.5%) of 74 
cases.2 Nonetheless, long-term follow-up data revealed that 
more than 90% of the patients experienced disease re­
mission. In this series, subtotal resection plus radiotherapy 
yielded excellent results. Although microneurosurgery has 
advanced along with imaging guidance, the risk of signifi­
cant morbidity remains if radical resection is the exclusive 
goal in each case.
Aggressive surgical management may not lead to optimal 
outcomes, and the current literature favors a limited surgical 
approach followed by radiotherapy.2-6-" The role of radio­
therapy in controlling tumor while maintaining good func­
tion of surrounding critical structures is well recognized, 
and craniopharyngiomas are generally considered radiosen­
sitive. Progression-free survival is improved significantly if 
radiotherapy is added to the treatment regimen postopera­
tively.7-1 l-L!-l9-2s-i<i-JS-41-44 Although long-term data are not avail­
able, the use of stereotactic radiosurgery has shown prom­
ising tumor control as well.5-2U3U With its known benefits 
and few side effects, radiation in conjunction with limit­
ed surgery in cases in which tumor is adhesive to critical
structures offers the best chance of controlling tumor and 
maintaining baseline quality of life. Additionally, the use of 
fractionated radiotherapy may further improve the ability to 
apply radiation near critical optic apparatus.41
Selection of the best management for craniopharyngioma 
ultimately depends on each patient’s age and medical condi­
tion, surgeon and patient preference, experience of the sur­
geon, and postoperative radiotherapy options available. One 
must recognize that advances in stereotactic radiosurgery 
alter traditional surgical paradigms. Resection via the TN 
route is a good option for performing a less morbid surgical 
procedure while allowing for the possibility of radical re­
section in appropriately selected cases. With cystic tumors, 
the TN approach can limit surgical morbidity and provide a 
good chance for complete resection.
Selection o f  Surgical Approach
Others have previously described their experience with 
the TN approach for craniopharyngioma.1-12-18-21-22-24-25-27 Au­
thors of another recent publication revisited the role of 
transsphenoidal surgery but did not include rigorous endo­
crine data.26 In 1932 Cushing9 was the first to use this ap­
proach for craniopharyngioma. Later, in 1963, Hardy and 
Lalonde14 repopularized the procedure. Since then, howev­
er, the TC approaches have been preferred in most cases ex­
cept solely intrasellar lesions (Fig. 1).
The discussion of which approach is appropriate often 
hinges on whether the tumor origin is above or below the 
diaphragma sellae. Most authors agree that the TN ap­
proach should be used in those cases in which the mass 
causes expansion of the sella. It is believed that this cir­
cumstance assures a tumor origin below the diaphragm and 
a good chance for total removal.6-18-25-27 Tumors below the 
diaphragm may remain intrasellar, causing expansion of 
the diaphragm, or may grow above the diaphragm, form­
ing a dumbbell-shaped lesion. These locations are amen­
able to TN approaches because expansion of the diaphragm, 
which acts as a barrier to pial invasion, facilitates complete 
resection.
We acknowledge a referral bias in the cases in this series, 
as sellar pathology is an area of expertise for the senior au­
thor. This fact may have affected the location of the tumors 
treated at our institution, as the majority of the tumors (57 
[66%] of 86) did have intrasellar involvement. In most re­
ports, intrasellar involvement occurs in approximately one 
third of the cases.21-27 In the TN cohort, however, there were 
only four cases of purely intrasellar craniopharyngioma, 53 
with an intrasellar component also had significant suprasel­
lar extension, and 11 were purely suprasellar. We believe
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these results support the use of the TN approach for prima­
ry treatment of craniopharyngioma, even in cases in which 
the tumor has a significant suprasellar presence, as recently 
reported by Maira, et al.26
Selection criteria for a particular approach in this series 
depended on whether the tumor was cystic. In cases in 
which the tumor was largely cystic or the majority of the 
solid portion was intrasellar, the lesion was removed via 
the TN approach. Therefore, suprasellar cystic tumors were 
accessed transnasally. Suprasellar solid tumors, however, 
were treated via the TC approach. During the TN approach, 
suprasellar cystic lesions are punctured and internally de­
compressed. Then the tumor capsule can be gently teased 
from surrounding structures and, in many cases, removed 
en bloc. In purely suprasellar cystic tumors, an extended TN 
approach is used. Clearly, surgeon comfort and experience 
are crucial in using this approach, but radical removal is 
possible and is justified by our experience, as we have com­
pleted total excision in many cases of suprasellar extension. 
This feat is not without risk, however, and considerable fa­
cility with the procedure is required.6
Others have noted that significant intracranial extension 
does not necessarily preclude the TN approach as long as 
the tumor is cystic and calcification— an indication of tu­
mor adhesiveness— is not significant.18-24 In these cases, pal­
liation can be achieved; however, these authors believe that 
total resection is unlikely in this scenario. Some assert that 
regardless of suprasellar extension, a TN approach should 
be used if any portion of the tumor is intrasellar, because it 
is less traumatic to the patient.27
The aim of our study was to analyze endocrine and clin­
ical outcomes in a series of patients harboring craniopha­
ryngioma that were treated mainly via the TN approach. In 
other series in which any cases were treated transnasally, the 
outcomes in comparison with those of the TC groups were 
always better.1 U2-27 In fact, significantly lower recurrence 
rates following subtotal resections of primarily intrasellar 
tumors have been reported."-22 These findings reflect the ex- 
trapial location of tumor as well as a smaller lesion size in 
cases selected for TN resection. As in our experience, oth­
ers have noted that intra- and suprasellar tumors are more 
often cystic and soft, whereas suprasellar tumors are solid.26
Irregularly shaped suprasellar tumors are difficult to re­
sect as they extend beneath the pia mater and have higher 
recurrence rates.27 These cases are most often approached 
transcranially, and thus it is difficult to compare outcomes 
directly between TC and TN surgical groups. Note, howev­
er, that duration of hospital stay, operating time, and blood 
loss were significantly lower in our TN cohort, corroborat­
ing the assumption that the TN approach is less invasive to 
the patient.
Recurrence Rates
The long-term outcomes in this series are acceptable and 
consistent with those in other reports in the literature.U2-18- 
21,22,24,26,27 -p^e generai consensus is that the best results with 
craniopharyngioma occur after complete excision of the tu­
mor, which should be the goal of the primary interven­
tion.'-6-12-18-21-22-24-25-27 Subtotal or partial resections create con­
ditions for recurrences, and repeated operations can prove 
even more difficult. Within this series, the TN approach did 
not limit our ability to achieve total resection.
The majority of relapses occur within the first 3 years af­
ter surgery.I2-18-40 The minimal follow up in the present series 
was 5 years, with many patients followed up for 10 years. 
Four (6.5%) of the 61 totally resected tumors in the TN 
group recurred and three (43%) of the seven subtotally re­
sected tumors enlarged. In other TN series reported, the 
rates between these two resection groups ranged from 0 to 
13% and 24 to 60%, respectively.1-12-18-21-22-24-25-27 Transcrani­
al totally resected craniopharyngioma operations generally 
yield recurrence rates from 7 to 13%.2-27-40-45 Among the sub­
totally resected cases, tumor growth occurred in 10 to 33%. 
The TC cohort in the present series had a 22% combined re­
growth and recurrence rate.
Visual Outcome
Most patients (80 of 86) in this series presented with vi­
sual loss. This fact attests to the preponderance of the su­
prasellar mass in this series. Rapid decompression of visual 
apparatus is one advantage of the TN approach. Vision im­
proved in 87% of cases; however, it deteriorated in two cas­
es in the TN group and in three cases in the TC group. In 
each of these cases, the tumors were exclusively suprasel­
lar. Visual improvement after TN surgery has been noted in 
70 to 94% of patients.I2-21-40 In the present study, visual out­
comes were worse in the TC cases. This finding likely is re­
lated to the fact that suprasellar solid tumors are more adhe­
sive to surrounding neural structures.
Endocrine Outcome
The TN approach likely leads to endocrinopathy, al­
though to what extent has yet to be clearly documented. On 
the other hand, the endocrine outcome in largely TC series 
has been reported.17 To our knowledge, this is the only re­
port with detailed endocrine outcomes in a largely TN series 
for craniopharyngioma. Almost no preoperative endocrin­
opathy improved after surgery. In fact, new postoperative 
endocrine abnormality should be expected following sur­
gery for craniopharyngioma.12-18 Some assert that the use of 
the TN approach is more appropriate in patients with hypo­
pituitarism because of the high rate of postoperative endo­
crinopathy.24
In the TN cohort, all categories of endocrinopathy were 
more common after surgery. The greatest increase was in 
the incidence of DI, which rose from 10 to 71%. Increases 
in DI have been well documented; however, in previous TN 
series, they have ranged from 11 to 30%.I7-25-27 The rates in 
the present study were higher and correlated more with 
those documented in mainly TC series in which radical re­
section was the goal.40-45 Other endocrine axes are not as 
well studied in the literature. In the TN cohort reported on 
here, changes in the other endocrine axes after surgery were 
less dramatic, although rates were generally higher on pre­
sentation compared with those in the TC group. The pa­
tients treated via the TC approach had more profound de­
terioration of endocrine function but presented with lower 
rates of deficiency; for example, hypothyroidism increased 
from 22.2 to 83.3%, DI from 11 to 61%, and hypocorti­
solemia from 17 to 61%.
In one study, resolution of an endocrine dysfunction oc­
curred in 19% of patients.21 This result was not reproduced 
in our experience. The reversal of endocrinopathy is rare. 
Hyperprolactinemia seems to be the most likely deficiency
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to improve, with eight of 16, three of three, and three of four 
cases improving in three separate series. l7-iV7 Hypogonad­
ism and GH secretion also have been shown to improve.17-’7
Cerebrospinal fluid (3HCG levels of 8 to 28 mlU/L were 
demonstrated in five cases of suprasellar solid lesions; how­
ever, surgical pathology results confirmed craniopharyngi­
oma. Raised (3HCG levels in the context of craniopharyn­
gioma have been reported.15 Its presence in the CSF may 
indicate leakage of tumor contents.
Postoperath ’e Hyperphagia
Hyperphagia was a postoperative occurrence that led to 
morbidity in a considerable number of patients: 40% (27 of 
68) and 61 % (11 of 18) of patients in the TN and TC groups, 
respectively. Hyperphagia and postoperative obesity are 
well-recognized complications in surgery for craniopharyn­
gioma,8-1 although both are mainly discussed in the 
nonsurgical literature. Authors of most surgical series do 
not discuss their presence or absence. Data from one large 
series demonstrated that both were very infrequent;1’ in an­
other, however, both occurred 35% of the time."
The origin of hyperphagia involves damage to the satiety 
center in the ventromedian hypothalamus.""*1 Results of 
pathological studies have shown the propensity for cranio­
pharyngioma to create finger-like projections within brain 
parenchyma, and these projections may lead to hypotha­
lamic injury when the tumor capsule is removed.3 In one 
study, authors used MR imaging confirmation of hypotha­
lamic damage in children with postoperative obesity fol­
lowing resection of craniopharyngioma.IH In some patients, 
psychosocial difficulties occur and can be overwhelming to 
family members, with rehabilitation proving very difficult.! ! 
Little is written about this unfortunate complication.
Despite the relative ease of tumor dissection in most cas­
es in the present study, hypothalamic injury did occur in 
some. This result should serve as a warning to exercise cau­
tion while performing a dissection near the hypothalamus 
and sharply amputate the tumor capsule in this area. Postop­
erative obesity reported in this series likely represents the 
true incidence of this complication of craniopharyngioma 
removal. Future investigators should focus more on its ram­
ifications and neuropsychological outcomes.
Conclusions
For cystic craniopharyngioma along the hypothalamo- 
pituitary axis, the TN approach provided a less invasive 
method with good outcome. Suprasellar solid tumors fared 
worse with regard to endocrine, visual, and hypothalamic 
injury. Postoperative obesity is a significant problem. For 
the goal of palliation, the role of the TN approach is clear. 
In a surprising number of cases, however, radical resection 
was also possible by using an extended TN route.
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